Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Modified Xiao-Feng Powder in the Treatment of Chronic Urticaria - A Double-Blind Randomized Placebo-Controlled Study

NCT04967092 is registered in ClinicalTrials.gov with Prof. Lin Zhixiu as lead sponsor.

NCT NCT04967092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04967092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Modified Xiao-Feng Powder in the Treatment of Chronic Urticaria - A Double-Blind Randomized Placebo-Controlled Study
Lead sponsor
Prof. Lin Zhixiu
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2021
Completion date
April 7, 2023
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic urticaria